In order to meet the challenges of rising product development costs, generics, and patent cliffs, the biopharma industry must utilize information technology. We have the opportunity to tackle our challenges through technology-based collaborations to plan, design, and execute clinical development. This webinar will explore how biopharma can use information technology to bring drugs to market faster, better, and cheaper.
Partnerships with a technology focus demand a move toward a relationship where trust is built through transparency and shared access to data. This allows side-by-side collaboration to identify signals and trends and make proactive decisions. Companies that fully grasp the trust-through-transparency partnership model know access to data essential, not physical custody. As a result, these companies are reaping the greatest rewards from new technology.
Moreover, sponsors and CROs alike can use technology solutions to drive more effective processes — triggers, alerts, and calls to action — to improve efficiency during each cycle within a clinical trial, such as:
- Identifying suitable sites via historic information;
- Having access to recruitment data across sites, studies, regions or therapeutics;
- Using maintenance data on protocol deviations, queries, and subject safety issues; and
- Knowing that at database lock, information points to where efforts should be focused, we can optimize processes for productivity, efficiency, and value.
Tom Grundstrom, Vice President & Global Head, Integrated Processes and Technologies, Quintiles Infosario
Thomas (Tom) Grundstrom is Vice President, Integrated Processes and Technologies, as well as the Global Head of Quintiles Infosario®. In this role, he oversees the design, development and adoption of Quintiles Infosario, which seamlessly integrates data, Quintiles’ systems, processes and therapeutic expertise to provide data transparency, optimized workflows and insights that drive faster, better-informed decisions.
Prior to this role, Tom served as Vice President of Global Data Solutions at Quintiles where he led the solutions team responsible for integrating Clinical Data Management, Central Labs, Cardiac Safety, Biostatistics, Phase I and Interactive Response Technology business units. Before joining Quintiles, Tom served in a variety of senior roles with both MDS Pharma Services and LabCorp. He has extensive experience directing the development of global systems in North America, South America, Europe, Australia and Asia.
Mark Gorton, Senior Director of Information Technology, Quintiles
Mark Gorton serves as the Product Manager for Infosario Analytics, Quintiles award-winning platform that integrates a multitude of data sources and provides a means by which sponsors, sites, and Quintiles staff can effectively oversee and manage clinical trials and programs. Mark is responsible for leading the development efforts, overseeing quality, and guiding the future of Infosario Analytics. Mark brings both technical and leadership to the Infosario team with his experience working with large, diverse data sets and systems; and leading international teams to deliver technology based solutions to business requirements.
Who Should Attend?
EVPs, VPs, Directors, Heads, Managers, Principal Scientists of:
- Clinical R&D
- Clinical Operations (Clinical Project Leads, Clinical Program Managers, Therapeutic Heads, Clinical Data Managers, Pharmacovigilance Scientist)
- Regulatory Affairs
- Medical Affairs
- Outsourcing Management
Quintiles is the only fully integrated bioPharmaceutical services company offering clinical, commercial, and consulting solutions worldwide. The Quintiles network of more than 27,000 engaged professionals in 59 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps bioPharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.